GoPower offers comprehensive portable solar energy solutions, designed to save you money and reduce your environmental impact. Their user-friendly solar panels eliminate the need for complex installations, allowing easy setup anywhere. Their portable solar power stations, providing up to 1000w/1280WH at 240v, are perfect for various applications such as home offices, garden rooms, boats, events, and more. With multiple output sockets and versatile charging options including solar panels and mains electricity, GoPower provides a greener and cost-effective energy alternative.
days to go:
Extended
investment:
£10,000
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Rype addresses the dilemma of choosing between expensive or low-quality office furniture that contributes to carbon emissions and waste. By remanufacturing high-quality used office furniture, Rype offers cost-effective solutions with 80% lower carbon emissions and waste, while creating local jobs. Their mission is to significantly reduce office carbon emissions and costs through sustainable, circular economy practices, including exclusive furniture ranges made from waste materials. Rype's comprehensive services encompass furniture sourcing, remanufacturing, and employing marginalized individuals, contributing to a more environmentally friendly and socially responsible approach to office furnishings.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Maven Leisure Limited, or Maven, is being established by the current owners and senior management of ETM Group Limited, which operates 13 premium bars, pubs and restaurants in Central London including, rooftop bar Aviary, The Botanist Sloane Square, premium sports bars Greenwood, Westwood and Redwood and its brew and sports pub, Long Arm Pub and Brewery. Maven's founders aim to take advantage of favourable market conditions and raise third-party capital to fund anticipated growth over the next three to five years. ETM asserts that it has grown from a single site to a business turning over c.£35 million and generating c.£3.2 million EBITDA with no external equity funding since its formation in 2013. It aspires to take Maven towards profitability. Maven cites data stating that sector experts predict a rapid return to previous levels of business in the hospitality sector once the Covid-19 lockdown is relaxed. It aims to capitalise on this sentiment and use the investment to grow its profitability across different verticals.
days to go:
Expired
investment:
Withheld
PonchoPay aims to change the way parents pay for childcare and access the government funding they're entitled to.
Hundreds of millions of pounds of government support available to parents is going unspent each year due to poor awareness, clunky processes and a low adoption of technology. PonchoPay is making it easy for any source of funding to be aggregated at point of checkout, saving parents money and saving childcare providers a significant amount of time in the process.
Using Poncho Pay's intelligent automation engine, our vision is for parents to be able to quickly access and use this funding across all childcare providers that are registered to receive them nationwide.
As we build our prominent role in the payment journey, PonchoPay will be well positioned to offer additional services in future to parents and childcare providers alike. Growth capital and insurance solutions for childcare providers, Buy Now Pay Later for parents and AI-powered booking curation tools are a handful of additional revenue sources that we plan to explore in the future.
days to go:
Expired
investment:
£405,860
PathCloud aims to assemble the global clinical diagnostics resources and data and make them safely available and helpful. The company has created and tested one of the first scalable clinical diagnostics management platforms. It currently has 20,000 clinicians partner networks and 92 registered clinicians. Additionally, it has a network across 48 counties, has over 100 providers, over 3500 diagnostics tests registered and over 10,000 patients by partner telemedicine networks. These funds will be used to gain a significant portion of diagnostics supplier agreements towards the scaling objective, increase efforts towards the international markets and NHS and pursue telemedicine networks.
days to go:
Expired
investment:
£81,720
Lifetise is a financial planning platform that enables prospective clients to plan significant expenditures such as buying a home, marital expenses, child-rearing and retirement. Presently, they have come up with two major offerings: Homefinder and Childminder. The first one acts as a tool that shows money required to afford a home in the UK and the amount of time taken to save the money while the latter helps parents to calculate the costs of childcare along with their work. Lifetise is targeting the 25-40 age group in the UK whose population numbers are approximately 14 million. To date, they have been featured in prominent publications like Evening Standard and Stylist with an active following on Reddit. The company has secured 12,000 customers after their partnering with Accenture's Fintech Accelerator Programme. With the investment, Lifetise will spend more on developing its applications with a focus on all major life expenditures, marketing on social media channels, build partnerships and human resources.
days to go:
Expired
investment:
£254,240
